The added benefit of contrast-enhanced CT in evaluation of incidental FDG-avid colon lesions
Eur J Nucl Med Mol Imaging
.
2020 Sep;47(10):2244.
doi: 10.1007/s00259-020-04716-y.
Epub 2020 Feb 12.
Authors
Joseph C Lee
1
2
,
Gemma F Hartnett
3
4
,
Aravind S Ravi Kumar
5
6
Affiliations
1
Department of Medical Imaging, The Prince Charles Hospital, Chermside, 4032, Australia. Joseph.Lee@health.qld.gov.au.
2
Faculty of Medicine, University of Queensland, Herston, 4006, Australia. Joseph.Lee@health.qld.gov.au.
3
Faculty of Medicine, University of Queensland, Herston, 4006, Australia.
4
Department of Medical Oncology, Redcliffe General Hospital, Redcliffe, 4020, Australia.
5
Department of Molecular Imaging and Therapeutic Nuclear Medicine, Peter MacCallum Cancer Centre, Melbourne, 3000, Australia.
6
Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, 3052, Australia.
PMID:
32052097
DOI:
10.1007/s00259-020-04716-y
No abstract available
Publication types
Letter
Comment
MeSH terms
Colon
Fluorodeoxyglucose F18*
Humans
Positron-Emission Tomography*
Radiopharmaceuticals
Tomography, X-Ray Computed
Substances
Radiopharmaceuticals
Fluorodeoxyglucose F18